Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: 336 non-final action
40
Jul 11, 2008 05:47AM
5
Jul 11, 2008 05:54AM

Jul 11, 2008 05:55AM

Jul 11, 2008 06:04AM

Jul 11, 2008 06:06AM

Whats important is the last non-final action and in the last para of page 5 and the first para of page 6 is where Ledzius is truly considered. Then throughout the letter, the concept of using the same substrate obtained from ledzius is what is repeated. I believe that no other aspect of ledzius's design matters since it is not specified in the non-final action. Read the 1st para of page 16 where it is stated that Kato and Ledzius encompass all teachings from the other two control numbers for the 336. If any other aspect of Ledzius mattered it would have been stated in the letter.

2
Jul 11, 2008 09:35AM

Jul 11, 2008 10:09AM
2
Jul 11, 2008 10:48AM
30
Jul 11, 2008 03:14PM
13
Jul 11, 2008 04:18PM
Share
New Message
Please login to post a reply